Medpace Board Approves $1 Billion Stock Repurchase Authorization
Photo: TokenPost
Medpace Holdings Inc. posted $716.0 million in revenue for the third quarter ended Sept. 30, an 8.5% increase from a year earlier. The board also approved an authorization for up to $1 billion in stock repurchases. Net income was $137.5 million, and GAAP diluted EPS was $4.84. In the same quarter of 2025, net income was $111.1 million, or $3.86 per diluted share. Medpace released the results at 8:15 p.m. ET Oct. 21 (00:15 UTC Oct. 22). Revenue in the year-earlier quarter totaled $659.9 million. The latest reported growth rate was 8.5%, compared with 8.6% on a constant-currency basis.
Source: TokenPost
